TRACON Pharmaceuticals (TCON) Stock Chart & Stock Price History → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free TCON Stock Alerts $1.76 -0.06 (-3.30%) (As of 02:06 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media TRACON Pharmaceuticals Stock Price Performance5 Day Performance-5.38%1 Month Performance-54.17%3 Month Performance-55.03%6 Month Performance-44.48%Year-To-Date Performance-49.74%1 Year Performance-87.87% Receive TCON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide TCON Stock Chart for Wednesday, May, 8, 2024 TCON Chart by TradingView TRACON Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$1.81$1.82+0.55%$1.84$1.7490,867 shs$4.15 million05/06/2024$1.86$1.81-2.69%$1.92$1.77106,509 shs$4.13 million05/03/2024$1.81$1.86+2.76%$1.94$1.80260,844 shs$4.24 million05/02/2024$1.71$1.81+5.85%$1.87$1.72144,773 shs$4.13 million05/01/2024$1.73$1.71-1.16%$1.85$1.69187,825 shs$3.90 million04/30/2024$1.88$1.73-7.98%$1.95$1.70191,012 shs$3.94 million Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$1.81$1.88+3.87%$2.10$1.81243,119 shs$4.29 million04/26/2024$1.79$1.81+1.12%$1.88$1.70206,618 shs$4.13 million04/25/2024$1.89$1.79-5.29%$1.97$1.76128,568 shs$4.08 million04/24/2024$1.85$1.89+2.16%$1.94$1.8364,665 shs$4.30 million04/23/2024$1.82$1.85+1.65%$1.96$1.8254,919 shs$4.22 million04/22/2024$1.96$1.82-7.14%$1.94$1.70143,340 shs$4.15 million04/19/2024$2.11$1.96-7.11%$2.14$1.93239,102 shs$4.47 million04/18/2024$2.29$2.11-7.86%$2.34$2.06351,085 shs$4.81 million04/17/2024$1.71$2.29+33.92%$2.89$1.711.97 million shs$5.22 million04/16/2024$1.80$1.71-5.00%$1.93$1.59263,900 shs$3.90 million04/15/2024$2.36$1.80-23.73%$2.28$1.72253,730 shs$4.10 million04/12/2024$2.59$2.36-8.88%$2.65$2.25307,162 shs$5.38 million04/11/2024$3.01$2.59-13.95%$3.37$2.55214,005 shs$117.86 million04/10/2024$3.36$3.01-10.47%$3.14$2.70285,094 shs$136.97 million04/09/2024$3.84$3.36-12.45%$4.08$3.03203,320 shs$7.65 million04/08/2024$5.11$3.84-24.79%$5.00$3.70343,615 shs$8.74 million04/05/2024$5.25$5.11-2.67%$5.40$4.6094,143 shs$11.62 million04/04/2024$4.39$5.25+19.50%$5.58$4.52430,170 shs$11.94 million04/03/2024$8.31$4.39-47.18%$8.08$3.72841,811 shs$9.99 million04/02/2024$8.23$8.31+1.05%$8.54$8.0057,583 shs$18.91 million04/01/2024$8.60$8.23-4.30%$8.83$8.2069,365 shs$18.72 million03/29/2024$8.60$8.60$9.20$7.94156,697 shs$19.56 million03/28/2024$8.20$8.60+4.80%$9.20$7.94155,517 shs$19.56 million03/27/2024$8.60$8.20-4.63%$8.60$7.8079,852 shs$18.66 million03/26/2024$9.20$8.60-6.52%$9.20$7.80167,323 shs$19.57 million03/25/2024$9.13$9.20+0.74%$10.00$8.81184,200 shs$20.93 million03/22/2024$8.74$9.13+4.49%$11.00$8.90506,909 shs$20.78 million03/21/2024$7.44$8.74+17.47%$9.00$7.21310,354 shs$19.89 million03/20/2024$7.79$7.44-4.49%$8.00$7.02114,730 shs$16.93 million03/19/2024$7.22$7.79+7.86%$10.20$6.74448,179 shs$17.73 million03/18/2024$7.50$7.22-3.71%$7.60$5.78418,046 shs$16.43 million03/15/2024$8.75$7.50-14.31%$8.60$7.02326,652 shs$11.68 million03/14/2024$12.62$8.75-30.65%$12.40$7.131.03 million shs$13.63 million03/13/2024$7.80$12.62+61.79%$14.75$7.801.32 million shs$19.65 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$5.80$7.80+34.48%$8.02$6.30925,830 shs$12.15 million03/11/2024$4.94$5.80+17.41%$5.88$4.62372,426 shs$9.03 million03/08/2024$4.65$4.94+6.24%$5.20$4.50268,862 shs$7.69 million03/07/2024$3.94$4.65+18.02%$4.80$3.82349,401 shs$7.24 million03/06/2024$3.75$3.94+5.07%$4.00$3.50128,516 shs$6.14 million03/05/2024$3.77$3.75-0.53%$3.80$3.4870,087 shs$5.84 million03/04/2024$3.76$3.77+0.27%$3.80$3.4444,095 shs$5.87 million03/01/2024$3.62$3.76+3.87%$3.95$3.5973,304 shs$5.85 million02/29/2024$3.48$3.62+3.90%$3.78$3.4844,698 shs$5.64 million02/28/2024$3.56$3.48-2.08%$3.69$3.3720,201 shs$5.43 million02/27/2024$3.66$3.56-2.79%$3.71$3.5326,452 shs$5.54 million02/26/2024$3.32$3.66+10.17%$3.66$3.2629,195 shs$5.70 million02/23/2024$3.60$3.32-7.62%$3.58$3.1766,751 shs$5.17 million02/22/2024$3.62$3.60-0.72%$3.66$3.4432,266 shs$5.60 million02/21/2024$3.72$3.62-2.69%$3.76$3.6017,433 shs$5.64 million02/20/2024$3.74$3.72-0.37%$3.80$3.6020,592 shs$5.80 million02/19/2024$3.74$3.74$3.80$3.6217,915 shs$5.82 million02/16/2024$3.80$3.74-1.79%$3.80$3.6217,547 shs$5.82 million02/15/2024$3.80$3.80+0.11%$3.94$3.6048,056 shs$5.92 million02/14/2024$3.90$3.80-2.56%$4.00$3.6448,371 shs$5.92 million02/13/2024$3.99$3.90-2.26%$4.00$3.8313,085 shs$6.07 million02/12/2024$3.76$3.99+6.17%$4.00$3.7454,135 shs$6.21 million02/09/2024$3.91$3.74-4.50%$3.91$3.6435,391 shs$5.82 million02/08/2024$3.92$3.91-0.05%$4.08$3.8026,492 shs$6.09 million02/07/2024$3.80$3.92+3.05%$3.92$3.7324,541 shs$6.10 million Related Companies: Finch Therapeutics Group Stock Chart Kiromic BioPharma Stock Chart Avalon GloboCare Stock Chart Eloxx Pharmaceuticals Stock Chart Palisade Bio Stock Chart Gamida Cell Stock Chart Fresh Tracks Therapeutics Stock Chart Creative Medical Technology Stock Chart Titan Pharmaceuticals Stock Chart SQZ Biotechnologies Stock Chart Receive TCON Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCON) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.